Selected article for: "ace function and activity essential"
Author: Hsieh, Wen-Yeh; Kuan, Tang-Ching; Cheng, Kun-Shan; Liao, Yan-Chiou; Chen, Mu-Yuan; Lin, Pei-Heng; Hsu, Yuan-Chang; Huang, Chen-Yi; Hsu, Wei-Hua; Yu, Sheng-Yao; Lin, Chih-Sheng
Title: ACE/ACE2 Ratio and MMP-9 Activity as Potential Biomarkers in Tuberculous Pleural Effusions
  • Document date: 2012_10_17
    • ID: zlzig0nn_37
    Snippet: Our data suggest that the interplay between ACE and ACE2, an essential function in RAS, and the change in gelatinase activity may be involved in the development of pleural effusions. Our findings suggest that increased ACE and MMP-9 activities and decreased ACE2 activity in pleural fluid are features of pleural space infection in patients with pleural tuberculosis. Such measurements may be helpful for diagnosing tuberculous pleurisy. However, the.....
    Document: Our data suggest that the interplay between ACE and ACE2, an essential function in RAS, and the change in gelatinase activity may be involved in the development of pleural effusions. Our findings suggest that increased ACE and MMP-9 activities and decreased ACE2 activity in pleural fluid are features of pleural space infection in patients with pleural tuberculosis. Such measurements may be helpful for diagnosing tuberculous pleurisy. However, the findings of the present study require further validation in a large prospective study examining the treatment and outcome of unselected patients with tuberculosis before the above indicators can become part of a clinically meaningful practice.

    Search related documents:
    Co phrase search for related documents
    • ACE activity and pleural effusion: 1, 2, 3
    • ACE activity and pleural fluid: 1, 2, 3
    • ACE activity and pleural tuberculosis: 1
    • ACE activity and present study: 1, 2, 3, 4, 5, 6
    • ACE activity and prospective study: 1, 2, 3
    • essential function and present study: 1, 2, 3, 4, 5
    • gelatinase activity and pleural fluid: 1
    • outcome treatment and pleural effusion: 1, 2, 3, 4, 5, 6, 7, 8
    • outcome treatment and pleural fluid: 1
    • outcome treatment and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • outcome treatment and present study finding: 1
    • outcome treatment and prospective study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • pleural effusion and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • pleural effusion and prospective study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • pleural effusion and space infection: 1
    • pleural effusion development and prospective study: 1
    • pleural fluid and present study: 1, 2, 3
    • pleural fluid and prospective study: 1, 2, 3, 4, 5
    • pleural fluid and space infection: 1